Ryerson Holding Corp (RYZ) stock
Close on Nov 17, 2026Market cap $1.46BP/E –Yield 2.65%
Earnings
Ryerson's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Ryerson's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q4 FY2026ended Dec 31, 2026 | Feb 18, 2027Expected | – | – | – | – | – |
| Q3 FY2026ended Sep 30, 2026 | Oct 28, 2026after the close | $2.18B | +87.9% | $0.61 | $0.61 | Release |
| Q2 FY2026ended Jun 30, 2026 | Jul 29, 2026during market hours | $2.01B | +71.8% | $0.30 | $0.52 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 6, 2026during market hours | $1.57B | +37.7% | $0.10 | $0.30 | Release |
| Q4 FY2025ended Dec 31, 2025 | Feb 19, 2026during market hours | $1.10B | +8.9% | -$1.18 | -$1.01 | Release |
| Q3 FY2025ended Sep 30, 2025 | Oct 28, 2025during market hours | $1.16B | +2.7% | -$0.46 | -$0.46 | Release |
| Q2 FY2025ended Jun 30, 2025 | Jul 29, 2025during market hours | $1.17B | -4.9% | $0.06 | – | Release |
| Q1 FY2025ended Mar 31, 2025 | Apr 30, 2025during market hours | $1.14B | -8.1% | -$0.18 | -$0.18 | Release |
| Q4 FY2024ended Dec 31, 2024 | Feb 20, 2025during market hours | $1.01B | -8.2% | – | -$0.14 | Release |
| Q3 FY2024ended Sep 30, 2024 | Oct 29, 2024during market hours | $1.13B | -9.6% | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Jul 30, 2024during market hours | $1.23B | -8.4% | $0.29 | $0.33 | Release |
| Q1 FY2024ended Mar 31, 2024 | Apr 30, 2024during market hours | $1.24B | -11.4% | -$0.22 | -$0.18 | Release |
| Q4 FY2023ended Dec 31, 2023 | Feb 21, 2024during market hours | $1.10B | -14.6% | $0.74 | $0.73 | Release |
| Q3 FY2023ended Sep 30, 2023 | Oct 30, 2023during market hours | $1.25B | – | $1.00 | $1.00 | Release |
| Q2 FY2023ended Jun 30, 2023 | Jul 31, 2023during market hours | $1.34B | – | $1.06 | $1.06 | Release |
| Q1 FY2023ended Mar 31, 2023 | May 1, 2023during market hours | $1.40B | – | $1.27 | $1.27 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 22, 2023during market hours | $1.29B | – | -$0.65 | -$0.65 | Release |
| Q3 FY2022ended Sep 30, 2022 | Oct 11, 2022during market hours | – | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Jul 11, 2022during market hours | – | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | Apr 13, 2022during market hours | – | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Feb 3, 2022during market hours | – | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Oct 21, 2021during market hours | – | – | – | – | Release |
| Q1 FY2021ended Mar 31, 2021 | Jul 22, 2021during market hours | – | – | – | – | Release |
| Q4 FY2020ended Dec 31, 2020 | Jan 28, 2021during market hours | – | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Oct 15, 2020during market hours | – | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Jul 14, 2020during market hours | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Ryerson's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net salesGAAP | Q4 FY2026 | $1.96B – $2.04B | – | New | Oct 28, 2026 |
| Adjusted EBITDA, excluding LIFOnon-GAAP | Q4 FY2026 | $100.00M – $104.00M | – | New | Oct 28, 2026 |
| diluted shareGAAP | Q4 FY2026 | $0.30 – $0.38 | – | New | Oct 28, 2026 |
| additional inventory purchase accounting charges | FY2026 | $5.00M – $7.00M | – | New | Jul 29, 2026 |
Guidance vs results
The last range Ryerson gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q3 FY2026 | diluted share | $0.37 – $0.40 | $0.61 | Above range |
| Q3 FY2026 | Revenue | $1.87B – $1.95B | $2.18B | Above range |
| Q2 FY2026 | EPS (GAAP) | $0.38 – $0.42 | $0.30 | Below range |
| Q2 FY2026 | Revenue | $1.86B – $1.93B | $2.01B | Above range |
| Q1 FY2026 | Revenue | $1.52B – $1.58B | $1.57B | Within range |
| Q4 FY2025 | EPS (GAAP) | -$0.28 – -$0.22 | -$1.18 | Below range |
| Q4 FY2025 | Revenue | $1.07B – $1.11B | $1.10B | Within range |
| Q3 FY2025 | EPS (GAAP) | $0.00 – $0.06 | -$0.46 | Below range |
| Q3 FY2025 | Revenue | $1.14B – $1.18B | $1.16B | Within range |
| Q2 FY2025 | EPS (GAAP) | $0.07 – $0.14 | $0.06 | Below range |
| Q2 FY2025 | Revenue | $1.15B – $1.19B | $1.17B | Within range |
| Q1 FY2025 | EPS (GAAP) | -$0.27 – -$0.20 | -$0.18 | Above range |
| Q1 FY2025 | Revenue | $1.12B – $1.15B | $1.14B | Within range |
| Q4 FY2024 | Revenue | $1.00B – $1.04B | $1.01B | Within range |
| Q3 FY2024 | Revenue | $1.12B – $1.16B | $1.13B | Within range |
| Q2 FY2024 | EPS (GAAP) | $0.15 – $0.25 | $0.29 | Above range |
| Q2 FY2024 | Revenue | $1.25B – $1.29B | $1.23B | Below range |
| Q1 FY2024 | EPS (GAAP) | $0.24 – $0.34 | -$0.22 | Below range |
| Q1 FY2024 | Revenue | $1.21B – $1.25B | $1.24B | Within range |
| Q4 FY2023 | EPS (GAAP) | $0.18 – $0.22 | $0.74 | Above range |
| Q4 FY2023 | Revenue | $1.00B – $1.15B | $1.10B | Within range |
| Q3 FY2023 | EPS (GAAP) | $0.31 – $0.43 | $1.00 | Above range |
| Q3 FY2023 | Revenue | $1.25B – $1.30B | $1.25B | Within range |
| Q2 FY2023 | EPS (GAAP) | $1.28 – $1.36 | $1.06 | Below range |
| Q2 FY2023 | Revenue | $1.40B – $1.44B | $1.34B | Below range |
| Q1 FY2023 | EPS (GAAP) | $0.98 – $1.06 | $1.27 | Above range |
| Q1 FY2023 | Revenue | $1.37B – $1.43B | $1.40B | Within range |
Guidance history
Every forecast Ryerson put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Oct 28, 2026 | Adjusted EBITDA, excluding LIFO | Q4 FY2026 | $100.00M – $104.00M | New |
| Oct 28, 2026 | diluted share | Q4 FY2026 | $0.30 – $0.38 | New |
| Oct 28, 2026 | Net sales | Q4 FY2026 | $1.96B – $2.04B | New |
| Jul 29, 2026 | Adjusted EBITDA, excluding LIFO | Q3 FY2026 | $88.00M – $92.00M | New |
| Jul 29, 2026 | diluted share | Q3 FY2026 | $0.37 – $0.40 | New |
| Jul 29, 2026 | additional inventory purchase accounting charges | FY2026 | $5.00M – $7.00M | New |
| Jul 29, 2026 | shipments | Q3 FY2026 | -5% – -3% | New |
| Jul 29, 2026 | LIFO expense | Q3 FY2026 | $16.00M – $18.00M | New |
| Jul 29, 2026 | synergy benefits | Q3 FY2026 | $13.00M – $14.00M | Lowered |
| Jul 29, 2026 | net income generation | Q3 FY2026 | $19.00M – $21.00M | New |
| Jul 29, 2026 | Net sales | Q3 FY2026 | $1.87B – $1.95B | New |
| May 6, 2026 | Adjusted EBITDA, excluding LIFO | Q2 FY2026 | $88.00M – $92.00M | New |
| May 6, 2026 | diluted share | Q2 FY2026 | $0.38 – $0.42 | New |
| May 6, 2026 | Net income | Q2 FY2026 | $20.00M – $22.00M | New |
| May 6, 2026 | Net sales | Q2 FY2026 | $1.86B – $1.93B | New |
| Feb 19, 2026 | same-store customer shipments | Q1 FY2026 | +13% – +15% | New |
| Feb 19, 2026 | Adjusted EBITDA, excluding LIFO | Q1 FY2026 | $63.00M – $67.00M | New |
| Feb 19, 2026 | LIFO expense | Q1 FY2026 | $6.00M – $8.00M | New |
| Feb 19, 2026 | net income generation | Q1 FY2026 | $10.00M – $12.00M | New |
| Feb 19, 2026 | revenue | Q1 FY2026 | $1.52B – $1.58B | New |
| Oct 28, 2025 | Adjusted EBITDA, excluding LIFO | Q4 FY2025 | $33.00M – $37.00M | New |
| Oct 28, 2025 | loss per diluted share | Q4 FY2025 | -$0.28 – -$0.22 | New |
| Oct 28, 2025 | customer shipments | Q4 FY2025 | -7% – -5% | New |
| Oct 28, 2025 | LIFO expense | Q4 FY2025 | $10.00M – $14.00M | New |
| Oct 28, 2025 | net sales | Q4 FY2025 | $1.07B – $1.11B | New |
| Jul 29, 2025 | adjusted EBITDA, excluding LIFO | Q3 FY2025 | $40.00M – $45.00M | New |
| Jul 29, 2025 | earnings per diluted share | Q3 FY2025 | $0.00 – $0.06 | New |
| Jul 29, 2025 | customer shipments | Q3 FY2025 | -4% – -2% | New |
| Jul 29, 2025 | average selling prices | Q3 FY2025 | +1% – +3% | Raised |
| Jul 29, 2025 | LIFO expense | Q3 FY2025 | $9.00M – $11.00M | New |
| Jul 29, 2025 | net sales | Q3 FY2025 | $1.14B – $1.18B | New |
| Apr 30, 2025 | adjusted EBITDA, excluding LIFO | Q2 FY2025 | $40.00M – $45.00M | New |
| Apr 30, 2025 | earnings per diluted share | Q2 FY2025 | $0.07 – $0.14 | New |
| Apr 30, 2025 | customer shipments | Q2 FY2025 | -1% – +1% | New |
| Apr 30, 2025 | average selling prices | Q2 FY2025 | +3% – +4% | Raised |
| Apr 30, 2025 | LIFO expense | Q2 FY2025 | $5.00M – $7.00M | New |
| Apr 30, 2025 | net sales | Q2 FY2025 | $1.15B – $1.19B | New |
| Feb 20, 2025 | adjusted EBITDA, excluding LIFO | Q1 FY2025 | $28.00M – $32.00M | New |
| Feb 20, 2025 | loss per diluted share | Q1 FY2025 | -$0.27 – -$0.20 | New |
| Feb 20, 2025 | customer shipments | Q1 FY2025 | +11% – +13% | New |
| Feb 20, 2025 | average selling prices | Q1 FY2025 | 0% – +2% | Lowered |
| Feb 20, 2025 | LIFO expense | Q1 FY2025 | $6.00M – $8.00M | New |
| Feb 20, 2025 | net sales | Q1 FY2025 | $1.12B – $1.15B | New |
| Oct 29, 2024 | adjusted EBITDA, excluding LIFO | Q4 FY2024 | $10.00M – $12.00M | New |
| Oct 29, 2024 | loss per diluted share | Q4 FY2024 | -$0.53 – -$0.47 | New |
| Oct 29, 2024 | customer shipments | Q4 FY2024 | -10% – -8% | New |
| Oct 29, 2024 | average selling prices | Q4 FY2024 | -1% – +1% | Raised |
| Oct 29, 2024 | LIFO income | Q4 FY2024 | $10.00M | New |
| Oct 29, 2024 | net sales | Q4 FY2024 | $1.00B – $1.04B | New |
| Jul 30, 2024 | adjusted EBITDA, excluding LIFO | Q3 FY2024 | $21.00M – $25.00M | New |
| Jul 30, 2024 | earnings per diluted share | Q3 FY2024 | $0.01 – $0.10 | New |
| Jul 30, 2024 | customer shipments | Q3 FY2024 | +2% – +4% | New |
| Jul 30, 2024 | average selling prices | Q3 FY2024 | +3% – +5% | Raised |
| Jul 30, 2024 | LIFO income | Q3 FY2024 | $12.00M | New |
| Jul 30, 2024 | net sales | Q3 FY2024 | $1.12B – $1.16B | New |
| Apr 30, 2024 | capital expenditures | FY2024 | $110.00M | New |
| Apr 30, 2024 | capital expenditures | FY2025 | $50.00M | New |
| Apr 30, 2024 | adjusted EBITDA, excluding LIFO | Q2 FY2024 | $47.00M – $53.00M | New |
| Apr 30, 2024 | earnings per diluted share | Q2 FY2024 | $0.15 – $0.25 | New |
| Apr 30, 2024 | customer shipments | Q2 FY2024 | +1% – +3% | New |
| Apr 30, 2024 | average selling prices | Q2 FY2024 | 0% – +1% | Lowered |
| Apr 30, 2024 | LIFO expense | Q2 FY2024 | $1.00M | New |
| Apr 30, 2024 | net sales | Q2 FY2024 | $1.25B – $1.29B | New |
| Feb 21, 2024 | Adjusted EBITDA, excluding LIFO | Q1 FY2024 | $58.00M – $62.00M | New |
| Feb 21, 2024 | earnings per diluted share | Q1 FY2024 | $0.24 – $0.34 | New |
| Feb 21, 2024 | customer shipments | Q1 FY2024 | +8% – +10% | New |
| Feb 21, 2024 | average selling prices | Q1 FY2024 | +1% – +3% | Lowered |
| Feb 21, 2024 | revenue | Q1 FY2024 | $1.21B – $1.25B | New |
| Oct 30, 2023 | adjusted EBITDA, excluding LIFO | Q4 FY2023 | $28.00M – $32.00M | New |
| Oct 30, 2023 | earnings per diluted share | Q4 FY2023 | $0.18 – $0.22 | New |
| Oct 30, 2023 | average selling prices | Q4 FY2023 | +3% – +5% | New |
| Oct 30, 2023 | customer shipments | Q4 FY2023 | +4% – +7% | Raised |
| Oct 30, 2023 | LIFO income | Q4 FY2023 | $8.00M – $12.00M | New |
| Oct 30, 2023 | fourth-quarter net sales | Q4 FY2023 | $1.00B – $1.15B | New |
| Jul 31, 2023 | adjusted EBITDA, excluding LIFO | Q3 FY2023 | $43.00M – $47.00M | New |
| Jul 31, 2023 | earnings per diluted share | Q3 FY2023 | $0.31 – $0.43 | New |
| Jul 31, 2023 | customer shipments | Q3 FY2023 | +2% – +4% | New |
| Jul 31, 2023 | average selling prices | Q3 FY2023 | +1% – +2% | Lowered |
| Jul 31, 2023 | LIFO income | Q3 FY2023 | $2.00M | New |
| Jul 31, 2023 | net sales | Q3 FY2023 | $1.25B – $1.30B | New |
| May 1, 2023 | adjusted EBITDA, excluding LIFO | Q2 FY2023 | $93.00M – $97.00M | New |
| May 1, 2023 | earnings per diluted share | Q2 FY2023 | $1.28 – $1.36 | New |
| May 1, 2023 | pricing | Q2 FY2023 | 0% – +1% | New |
| May 1, 2023 | LIFO expense | Q2 FY2023 | $5.00M | New |
| May 1, 2023 | net sales | Q2 FY2023 | $1.40B – $1.44B | New |
| Feb 22, 2023 | adjusted EBITDA, excluding LIFO | Q1 FY2023 | $78.00M – $82.00M | New |
| Feb 22, 2023 | earnings per diluted share | Q1 FY2023 | $0.98 – $1.06 | New |
| Feb 22, 2023 | pricing | Q1 FY2023 | +1% – +3% | New |
| Feb 22, 2023 | shipment volumes | Q1 FY2023 | +10% – +12% | Raised |
| Feb 22, 2023 | LIFO expense | Q1 FY2023 | $5.00M | New |
| Feb 22, 2023 | net sales | Q1 FY2023 | $1.37B – $1.43B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Ryerson filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Results
- Results
- Update
- Results
- Results
- Update
- Update
- Update
- News
- Results
See a number that looks wrong?